Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-02-11Clinical Trial Update: Trans GERD: Efficacy and Tolerability of Esomeprazol in Patients Under Ordinary Medical Care Conditions
A completed clinical trial evaluating the efficacy and tolerability of esomeprazole for gastroesophageal reflux disease under ordinary medic…
-
FDA approval · 2008-02-06FDA Approved: ACID REDUCER PLUS ANTACID — Original Application (CVS Pharmacy)
FDA approved the original application for ACID REDUCER PLUS ANTACID, a combination product containing famotidine with calcium carbonate and …
-
CLINICAL_TRIALS trial_result · 2008-01-29Clinical Trial Update: German PMS Trial (AWB) to Evaluate Therapy in Reflux Disease and NSAR-Symptoms
A German post-marketing surveillance trial evaluating a therapy for reflux disease and NSAID-related symptoms has completed.
-
CLINICAL_TRIALS research · 2008-01-28Clinical Trial Update: Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs). [Phase 3]
Phase 3 clinical trial update evaluating tegaserod for GERD symptoms in patients with incomplete response to PPIs has been completed.
-
CLINICAL_TRIALS trial_result · 2008-01-28Clinical Trial Update: Assessment of the Effects of Tegaserod in the Management of Gastroesophageal Reflux Disease (GERD) in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs). [Phase 3]
Phase 3 trial evaluating tegaserod for gastroesophageal reflux disease in patients with incomplete response to proton pump inhibitors has co…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-01-25Clinical Trial Update: Examine National Characteristics & Outcome Measures of GERD Patients Using the PPI Acid Suppression Symptom (PASS) Test for Response [Phase 4]
Phase 4 trial evaluating national characteristics and outcome measures of gastroesophageal reflux disease patients using the PASS test to as…
-
CLINICAL_TRIALS trial_result · 2008-01-07Clinical Trial Update: Endoscopic Full-Thickness Plication for the Treatment of GERD: Long-Term Multicenter Results
This trial report summarizes the long-term, multicenter results of Endoscopic Full-Thickness Plication as a treatment for gastroesophageal r…
-
CLINICAL_TRIALS trial_result · 2008-01-07Clinical Trial Update: Study of the NDO Endoscopic Plication System For the Treatment of Symptomatic Gastroesophageal Reflux Disease [NA]
A completed clinical trial evaluated the NDO Endoscopic Plication System for symptomatic gastroesophageal reflux disease.
-
FDA approval · 2007-12-21FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for the combination product omeprazole and sodium bicarbonate from Oceanside Pharmaceuticals.
-
FDA approval · 2007-12-21FDA Approved: METOCLOPRAMIDE HYDROCHLORIDE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC.)
FDA approved a supplemental application for Metoclopramide Hydrochloride (generic) from Chartwell Governmental & Specialty RX, LLC. The acti…
-
FDA approval · 2007-12-20FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for PROTONIX DELAYED-RELEASE (pantoprazole sodium) from Wyeth Pharmaceuticals LLC, a subsidiary …
-
FDA approval · 2007-12-20FDA Approved: PROTONIX I.V. — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application to add an intravenous form of pantoprazole (PROTONIX I.V.), expanding the approved route of administ…
-
CLINICAL_TRIALS trial_result · 2007-12-18Clinical Trial Update: Study to Assess Management Strategies for the Use of Esomeprazole (Nexium) in Helicobacter Pylori Infected Patients [Phase 4]
Phase 4 clinical trial update on management strategies for using esomeprazole (Nexium) in patients infected with Helicobacter pylori, in the…
-
CLINICAL_TRIALS trial_result · 2007-12-12Clinical Trial Update: Study of Pantoprazole for Sleepiness Associated With Acid Reflux and Sleep Apnea [Phase 4]
A Phase 4 clinical trial evaluating pantoprazole for sleepiness associated with acid reflux and obstructive sleep apnea has completed.
-
CLINICAL_TRIALS trial_result · 2007-12-10Clinical Trial Update: Study Evaluating Pantoprazole in Adolescents With GERD [Phase 3]
Phase 3 trial evaluating pantoprazole in adolescents with gastroesophageal reflux disease has completed. Sponsor Wyeth is now part of Pfizer…
-
CLINICAL_TRIALS research · 2007-11-28Clinical Trial Update: SThe Effects of Melatonin on GERD Symptoms [Phase 1, Phase 2]
Phase 1/2 clinical trial update examining the effects of melatonin on gastroesophageal reflux disease symptoms.
-
FDA approval · 2007-11-14FDA Approved: PROTONIX DELAYED-RELEASE — Original Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved the original application for Pantoprazole sodium delayed-release (Protonix Delayed-Release) by Wyeth/Pfizer for the treatment o…
-
FDA approval · 2007-10-22FDA Approved: OMEPRAZOLE — Original Application (Apotex Corp)
FDA approved Apotex Corp's original application for a generic omeprazole product, enabling a generic option for treating gastroesophageal re…
-
FDA approval · 2007-10-22FDA Approved: OMEPRAZOLE — Original Application (Quallent Pharmaceuticals Health LLC)
FDA approved the original (ANDA) application for omeprazole from Quallent Pharmaceuticals Health LLC, authorizing a generic omeprazole produ…
-
FDA approval · 2007-09-21FDA Approved: RANITIDINE — Original Application (Pharmaceutical Associates, Inc.)
FDA approved an original application for ranitidine (generic) by Pharmaceutical Associates, Inc.
-
CLINICAL_TRIALS trial_result · 2007-09-17Clinical Trial Update: Comparison of the Nighttime Effects of Two Different Drugs on Subjects With GERD [Phase 4]
A Phase 4 clinical trial comparing the nighttime effects of two drugs in subjects with gastroesophageal reflux disease has completed.
-
CLINICAL_TRIALS research · 2007-09-06Clinical Trial Update: Determinants of Efficacy of EsophyX Treatment in Gastro-Esophageal Reflux Disease
A clinical trial update examining determinants of EsophyX efficacy in gastroesophageal reflux disease.
-
FDA approval · 2007-08-31FDA Approved: RANITIDINE — Original Application (Dr. Reddy's Laboratories Limited)
FDA approved the original ANDA for ranitidine from Dr. Reddy's Laboratories Limited, enabling a generic ranitidine product to be marketed in…
-
CLINICAL_TRIALS trial_result · 2007-08-17Clinical Trial Update: PPI Test in GP Patients [Phase 4]
Phase 4 clinical trial update indicates completion of a proton pump inhibitor test in general practitioner patients with gastroesophageal re…
-
CLINICAL_TRIALS trial_result · 2007-06-22Clinical Trial Update: Effects of AFQ056 and Baclofen on Meal-Induced Gastroesophageal Reflux [Phase 1]
Phase 1 trial evaluating the effects of mavoglurant (AFQ056) and baclofen on meal-induced gastroesophageal reflux in gastroesophageal reflux…